The “Next Normal” — Customer Perspectives on the Supply Chain after COVID-19
COVID-19 continues to test the industry at every point in the supply chain. How will this shape the future of our industry? TraceLink CEO Shabbir Dahod shares customer concerns about COVID-19, the pharma supply chain, and what the “next normal” will look like when we have met this challenge.
A Message to Our Customers on COVID-19
TraceLink continues to monitor COVID-19 updates, with the health and wellbeing of our customers and employees remaining our utmost priority.
Resolve Supply Disruptions Fast with Serialized Product Intelligence
Supply chain disruptions that result from serialization process exceptions can lead to drug shortages, scrapped product, and damaged reputations. TraceLink's Bharath Sundararaman explains how Serialized Product Intelligence helps manufacturers resolve exceptions fast and get products moving again.
TraceLink CEO on Tackling Drug Shortages
In an article first published with STAT News on March 11th, TraceLink’s CEO Shabbir Dahod shares his insights into how the pharma supply chain can work together to help combat drug shortages, and the processes that need to be improved upon to do so.